Hisense HD60 Demonstrated in Clinical Training at University Hospital of Valdecilla in Spain

Hisense, a manufacturer and provider of high-performance electronics and medical devices, recently participated at Spain’s University Hospital of Valdecilla clinical ultrasound in traumatology training program as part of the company’s effort for global expansion. Since the beginning of this year, Hisense has accelerated its entry into the international medical equipment market and continued market expansion in countries such as South Africa, Spain, and several other European countries.

The University Hospital of Valdecilla (El Hospital Universitario Marqués de Valdecilla), established in 1929, is a leading central hospital situated in the city of Santander, Cantabria, in Northern Spain. It is a prominent medical institution that represents the epitome of local medical and health care. The hospital boasts eight cutting-edge research centers, specializing in areas like lung and pancreas transplants, as well as children’s hematopoietic transplants. The medical care and quality provided at the hospital have earned it the QH Seal Two-Star recognition and IHHI (Children’s Hospital Humanization Index) certification. With over 20 service units, the hospital is equipped to provide comprehensive medical care.

The hospital is currently exploring personalized precision medicine, which combines daily diagnosis and treatment with cutting-edge laboratory technology to deliver comprehensive and precise data for experts across various fields to evaluate and address challenging issues.

One of the hospital’s ongoing personalized precision medicine projects is the use of ultrasound equipment for MSK trauma grade evaluation. Doctors can leverage ultrasound image diagnosis information to improve the treatment plan, track the actual effect of the treatment process, and evaluate rehabilitation.

Users were given ultrasound training in MSK and nerve pain management by the director of the Neurology Department of Ramón y Cajal University Hospital. The Hisense HD60’s ultrasound image resolution and ease-of-use impressed all who felt that it effectively fulfills the demanding requirements for trauma ultrasound.

Hisense has successfully introduced its ultrasound and medical display products to several countries, such as South Africa, the United Arab Emirates, Iraq, Indonesia, Thailand, and Germany. The company firmly believes that its future growth rests in the international market. Thus, it remains dedicated to expanding its global presence and providing excellent medical equipment to medical professionals and patients worldwide.

SourceHisense

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.